Parallel Advisors, LLC Revolution Medicines, Inc. Transaction History
Parallel Advisors, LLC
- $4.31 Billion
- Q1 2025
A detailed history of Parallel Advisors, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 511 shares of RVMD stock, worth $18,835. This represents 0.0% of its overall portfolio holdings.
Number of Shares
511
Previous 95
437.89%
Holding current value
$18,835
Previous $4,000
375.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RVMD
# of Institutions
296Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$630 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$494 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$488 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$350 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$293 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.23B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...